NTIC:NSD-Northern Technologies International Corporation (USD)

EQUITY | Specialty Chemicals | NASDAQ Global Market

Last Closing

USD 17.31

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Volume

0.03M

Analyst Target

USD 13.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Northern Technologies International Corp develops and markets proprietary environmentally beneficial products and services. The Company is engaged in developing, manufacturing and marketing ZERUST rust and corrosion inhibiting products and services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

+4.53 (+1.05%)

USD 214.93B
BCPC Balchem Corporation

+1.41 (+0.91%)

USD 4.49B
WDFC WD-40 Company

-1.18 (-0.51%)

USD 3.06B
IOSP Innospec Inc

+4.92 (+3.90%)

USD 3.02B
HWKN Hawkins Inc

-0.67 (-0.85%)

USD 1.59B
LWLG Lightwave Logic Inc

-0.13 (-3.21%)

USD 0.49B
HDSN Hudson Technologies Inc

-0.03 (-0.33%)

USD 0.47B
GEVO Gevo Inc

-0.04 (-5.36%)

USD 0.16B
ALTO Alto Ingredients Inc

-0.10 (-5.59%)

USD 0.14B
LOOP Loop Industries Inc

+0.01 (+0.35%)

USD 0.13B

ETFs Containing NTIC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 46.82% 100% F 91% A-
Dividend Return 0.59% 75% C 35% F
Total Return 47.41% 100% F 91% A-
Trailing 12 Months  
Capital Gain 51.18% 88% B+ 88% B+
Dividend Return 2.45% 100% F 38% F
Total Return 53.62% 88% B+ 89% A-
Trailing 5 Years  
Capital Gain 29.18% 36% F 70% C-
Dividend Return 8.02% 50% F 31% F
Total Return 37.20% 36% F 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.38% 69% C- 70% C-
Dividend Return 12.05% 69% C- 70% C-
Total Return 1.67% 67% D+ 41% F
Risk Return Profile  
Volatility (Standard Deviation) 49.85% 38% F 33% F
Risk Adjusted Return 24.16% 56% F 60% D-
Market Capitalization 0.06B 56% F 45% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.06 25% 26%
Price/Book Ratio 1.91 63% 49%
Price / Cash Flow Ratio 29.45 13% 9%
Price/Free Cash Flow Ratio 15.64 31% 17%
Management Effectiveness  
Return on Equity 8.61% 63% 73%
Return on Invested Capital 6.57% 63% 73%
Return on Assets 1.11% 63% 70%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector